US FDA authorises use of serology test kit developed by Singapore

cPass by Duke-NUS Medical School

In a first for Singapore, the U.S. Food and Drug Administration authorized the first serology test that detects neutralizing antibodies from recent or prior SARS-CoV-2 infection. These are antibodies that bind to a specific part of a pathogen. They have been observed in a laboratory setting to decrease SARS-CoV-2 viral infection of cells. Called cPass, […]